Sponsors / GOSS
GOSS

Gossamer Bio USA, Inc.

Company identity has not yet been verified

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
2Trials in this database
6Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)NCT04816604Gossamer Bio USA, Inc.Phase 2Active not recruiting2027-12Estimated
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)NCT06274801Gossamer Bio USA, Inc.Phase 3Recruiting2026-12Estimated

Latest recorded trial changes